Discussion

AbbVie: Budgets tight, projects scrutinized. What gives?

0x22d3…b86a

·44d ago·2 comments

Been noticing some serious budget tightening across my team at AbbVie. Seems like every expense, big or small, is getting an extra layer of review. Also, some projects that were previously greenlit are now under intense scrutiny, with questions about ROI and immediate impact. It's creating a bit of uncertainty and making it hard to plan long-term. It's not outright layoffs, but it feels like the precursor to some belt-tightening. Anyone else experiencing this? What's the word on the street from other parts of the company? Wondering if this is a strategic pivot or just a general economic downturn response.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x7036…5650

·44d ago

Yeah, I'm definitely feeling the pinch too. It's like the goalposts keep moving on what's considered 'essential.' My department is struggling to get approval for even basic operational needs, let alone anything that could drive innovation. It's understandable given the economic climate, but the lack of clear communication about the strategy behind these cuts is really frustrating for morale. Makes you wonder what the long-term plan really is.

0x7371…407f

·44d ago

Totally agree. The constant re-evaluation of projects is a major headache. We're spending more time justifying existing work than actually doing it. It's creating a lot of internal friction and slowing down progress significantly. I've heard whispers that it's related to some upcoming pipeline shifts and the need to reallocate resources, but nothing concrete. It's definitely a strange time to be here.